You’ve heard about hydroxychloroquine, but do you know about Remdesivir, Roivant, and Athersys? If you’re keeping an eye on a possible vaccine, do you know there are more than a dozen vaccine candidates that are either doing trials now or hoping to start soon? This tracker from healthcare news outlet STAT has you covered.
The tracker doesn’t include every possible drug and vaccine effort, but it does list some of the “most talked about” and sorts them to put the ones whose development is the furthest along at the top of the chart.
For drugs, the top entry is Remdesivir, which has begun phase 3 trials. It was previously tested on SARS, MERS, and Ebola, in the hopes that it could act as an all-purpose antiviral. Now it’s being tested on COVID-19 patients, although the phase 3 trials in China were both suspended due to a lack of eligible patients.
Burrow's Modular Index Wall Shelves Can Be Assembled 'In Just 15...
Among vaccines, the top entry is Moderna’s mRNA vaccine, which began its phase 1 trials in March. None of the vaccine candidates have yet begun phase 2 trials, meaning it will be a while before we even know if any of them work, much less get a worldwide supply manufactured and distributed. We may be years away from the first vaccine (the fastest vaccine ever developed took four years), but with this chart we can keep an eye on how that process is going.
